Michelle Sholzberg




Dr. Michelle Sholzberg received her MDCM and residency training in Internal Medicine at McGill University, completed additional postgraduate training in Hematology at the University of Toronto and a research hemostasis fellowship in Toronto and internationally. Dr. Sholzberg has a Master of Science from the University of Toronto in Clinical Epidemiology and Health Care Research and was awarded the Claire Bombardier award for career promise as a scientist. She is a clinician-investigator with a focus on coagulation, the Division Head of Hematology-Oncology and the Medical Director of the Coagulation Laboratory at St. Michael’s Hospital. She is also the Director of the Hematology-Oncology Clinical Research Group and Co-director of the Hematology-Immunology Translational Research Theme of the Li Ka Shing Knowledge Institute. Currently, she is involved in the study of: prediction tools for perioperative and traumatic bleeding, the intersection of women’s health and bleeding disorders, treatments for iron deficiency anemia, new treatments for immune thrombocytopenia and the management of COVID-19 coagulopathy.

Recent Publications

  1. Sholzberg, M, da Costa, BR, Tang, GH, Rahhal, H, AlHamzah, M, Baumann Kreuziger, L et al.. Randomized trials of therapeutic heparin for COVID-19: A meta-analysis. Res Pract Thromb Haemost. 2021;5 (8):e12638. doi: 10.1002/rth2.12638. PubMed PMID:34977448 PubMed Central PMC8681879.
  2. Weyand, AC, McGann, PT, Sholzberg, M. Sex specific definitions of anaemia contribute to health inequity and sociomedical injustice. Lancet Haematol. 2022;9 (1):e6-e8. doi: 10.1016/S2352-3026(21)00351-3. PubMed PMID:34971584 .
  3. Kamin Mukaz, D, Gergi, M, Koh, I, Zakai, NA, Judd, SE, Sholzberg, M et al.. Thrombo-inflammatory biomarkers and D-dimer in a biracial cohort study. Res Pract Thromb Haemost. 2021;5 (8):e12632. doi: 10.1002/rth2.12632. PubMed PMID:34934895 PubMed Central PMC8652130.
  4. Kaur, MN, Arnold, DM, Heddle, NM, Cook, RJ, Hsia, CC, Blostein, M et al.. Cost-effectiveness of eltrombopag versus intravenous immunoglobulin for the perioperative management of immune thrombocytopenia. Blood Adv. 2021; :. doi: 10.1182/bloodadvances.2021005627. PubMed PMID:34781363 .
  5. Arya, S, Siad, FM, Wilton, P, Page, D, Boma-Fischer, L, Floros, G et al.. Invisible bleeds: Lived experiences and barriers to care for men with hemophilia. J Thromb Haemost. 2022;20 (2):296-306. doi: 10.1111/jth.15570. PubMed PMID:34689399 .
  6. Sun, HL, Yang, M, Poon, MC, Lee, A, Robinson, KS, Sholzberg, M et al.. The impact of extended half-life factor concentrates on patient reported health outcome measures in persons with hemophilia A and hemophilia B. Res Pract Thromb Haemost. 2021;5 (7):e12601. doi: 10.1002/rth2.12601. PubMed PMID:34667922 PubMed Central PMC8505988.
  7. Sholzberg, M, Tang, GH, Rahhal, H, AlHamzah, M, Kreuziger, LB, Áinle, FN et al.. Effectiveness of therapeutic heparin versus prophylactic heparin on death, mechanical ventilation, or intensive care unit admission in moderately ill patients with covid-19 admitted to hospital: RAPID randomised clinical trial. BMJ. 2021;375 :n2400. doi: 10.1136/bmj.n2400. PubMed PMID:34649864 PubMed Central PMC8515466.
  8. Connors, JM, Brooks, MM, Sciurba, FC, Krishnan, JA, Bledsoe, JR, Kindzelski, A et al.. Effect of Antithrombotic Therapy on Clinical Outcomes in Outpatients With Clinically Stable Symptomatic COVID-19: The ACTIV-4B Randomized Clinical Trial. JAMA. 2021;326 (17):1703-1712. doi: 10.1001/jama.2021.17272. PubMed PMID:34633405 PubMed Central PMC8506296.
  9. Sholzberg, M, James, PD. Commentary: surviving sexism in bleeding disorders affecting women. Br J Haematol. 2022;196 (1):15-16. doi: 10.1111/bjh.17881. PubMed PMID:34618910 .
  10. Teichman, J, Nisenbaum, R, Lausman, A, Sholzberg, M. Suboptimal iron deficiency screening in pregnancy and the impact of socioeconomic status in a high-resource setting. Blood Adv. 2021;5 (22):4666-4673. doi: 10.1182/bloodadvances.2021004352. PubMed PMID:34459878 PubMed Central PMC8759118.
Search PubMed

Affiliations & Other Activities

  • Staff Physician, Division of Hematology, St. Michael’s Hospital
  • Assistant Professor, Department of Medicine, University of Toronto